AngioDynamics Reports Fiscal 2019 Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
AngioDynamics (ANGO) Misses Q3 EPS by 3c, Revenues Miss; Reiterates FY19 EPS/Revenue Mid-Point Guidance Below Consensus
April 2, 2019 7:04 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.19, $0.03 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $86.3 million versus the consensus estimate of $88.3 million.
Net sales of $86.3 million, an increase of 3.0% year over yearGross margin declined 10 basis points year over year to 54.1%GAAP EPS of $0.02 per share;... More